telmisartan has been researched along with Chronic Illness in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kar, SK; Srivastava, A | 1 |
| Chen, X; Lin, Y; Luo, W; Shi, Y; Song, A; Wang, W; Zeng, Y; Zhang, Y | 1 |
| Bhat, A; Chidambaram, SB; Essa, MM; Guillemin, GJ; Mani, S; Manivasagam, T; Rajamani, B; Ray, B; Sekar, S; Thenmozhi, AJ | 1 |
| Bednarski, R; Donderski, R; Heleniak, Z; Lizakowski, S; Manitius, J; Przybylska, M; Renke, M; Rutkowski, B; Rutkowski, P; Sulikowska, B; Tylicki, L | 1 |
| Anderson, C; Cukierman-Yaffe, T; Gao, P; Gerstein, HC; Teo, K; Yusuf, S | 1 |
| Inoue, T; Kawagoe, Y; Koide, H; Nakamura, T; Node, K; Suzuki, T; Ueda, Y | 1 |
| Abe, H; Adachi, H; Hattori, S; Irino, H; Kitada, H; Miyatake, K; Morisawa, D; Noda, Y; Sasaki, T; Yasuoka, Y | 1 |
| Knap, N; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M | 1 |
| Anderwald-Stadler, M; Bergmann, A; Clodi, M; Hülsmann, M; Luger, A; Morgenthaler, NG; Mörtl, D; Pacher, R; Pacini, G; Resl, M; Riedl, M; Stelzeneder, D; Struck, J; Tura, A | 1 |
| Mann, JF; Teo, KK; Tobe, S; Yusuf, S | 1 |
| Abutaleb, N | 1 |
| Aizawa, Y; Gurusamy, N; Kodama, M; Ma, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Bilo, G; Caldara, G; Chinello, C; Gianazza, E; Giuliano, A; Lombardi, C; Magni, F; Mainini, V; Parati, G; Piperno, A; Revera, M | 1 |
| Chen, XY; Wan, WY; Wang, WY; Zeng, YM; Zhang, YX | 1 |
| Deguchi, I; Fukuoka, T; Furuya, D; Tanahashi, N | 1 |
| Gremmler, B; Kisters, K; Kunert, M; Schleiting, H; Ulbricht, LJ | 1 |
| Aleksandrowicz, E; Larczyński, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
9 trial(s) available for telmisartan and Chronic Illness
| Article | Year |
|---|---|
Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease.
Topics: Adult; Amides; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fumarates; Humans; Kidney Diseases; Male; Middle Aged; Patient Safety; Renin-Angiotensin System; Severity of Illness Index; Telmisartan; Treatment Outcome | 2013 |
Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies.
Topics: Aged; Aged, 80 and over; Aging; Benzimidazoles; Benzoates; Cardiovascular Diseases; Chronic Disease; Cognition Disorders; Dementia; Disabled Persons; Female; Glucose Metabolism Disorders; Humans; Male; Middle Aged; Ramipril; Risk Factors; Telmisartan | 2015 |
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cholesterol; Chronic Disease; Creatinine; Female; Humans; Hypertension; Interleukin-6; Kidney Diseases; Male; Matrix Metalloproteinase 9; Middle Aged; Renal Insufficiency; Telmisartan; Triglycerides | 2008 |
Comparison of the effects of telmisartan and olmesartan on home blood pressure, glucose, and lipid profiles in patients with hypertension, chronic heart failure, and metabolic syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Chronic Disease; Female; Glycated Hemoglobin; Heart Failure; Heart Rate; Humans; Hypertension; Imidazoles; Lipid Metabolism; Lipids; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Natriuretic Peptide, Brain; Telmisartan; Tetrazoles | 2008 |
Spironolactone attenuates oxidative stress in patients with chronic kidney disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Creatinine; Cross-Over Studies; Dinoprost; Diuretics; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Spironolactone; Telmisartan | 2008 |
Interactions of glucose metabolism and chronic heart failure.
Topics: Benzimidazoles; Benzoates; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; Chronic Disease; Heart Failure; Humans; Lipid Metabolism; Middle Aged; Obesity; Telmisartan; Tetrazoles | 2009 |
Modulation of urinary peptidome in humans exposed to high altitude hypoxia.
Topics: Adult; Altitude; Benzimidazoles; Benzoates; Chronic Disease; Double-Blind Method; Female; Humans; Hypoxia; Male; Middle Aged; Peptides; Proteome; Proteomics; Telmisartan; White People | 2012 |
Effects of different AT1-receptor antagonists in the therapy of severe heart failure pretreated with ACE inhibitors.
Topics: Acrylates; Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biomarkers; Biphenyl Compounds; Blood Pressure; Cardiac Output; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Telmisartan; Tetrazoles; Thiophenes; Treatment Outcome; Vascular Resistance | 2007 |
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Topics: Acetylglucosaminidase; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Collagen Type III; Cross-Over Studies; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Potassium; Proteinuria; Renin-Angiotensin System; Spironolactone; Telmisartan | 2008 |
8 other study(ies) available for telmisartan and Chronic Illness
| Article | Year |
|---|---|
Attributions to new onset catatonic symptoms, late in the course of chronic schizophrenia.
Topics: Amlodipine; Antihypertensive Agents; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; GABA Modulators; Humans; Hydrochlorothiazide; Lorazepam; Male; Middle Aged; Schizophrenia; Telmisartan; Time | 2017 |
Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Chronic Disease; Disease Models, Animal; Endothelial Cells; Heart Diseases; Hypoxia; Male; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Telmisartan | 2018 |
Telmisartan Ameliorates Astroglial and Dopaminergic Functions in a Mouse Model of Chronic Parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin II Type 1 Receptor Blockers; Animals; Astrocytes; Chronic Disease; Corpus Striatum; Disease Models, Animal; Dopamine; Gene Expression Regulation; Glutathione; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Nitric Oxide; Parkinsonian Disorders; Psychomotor Disorders; Substantia Nigra; Telmisartan; Walking | 2018 |
Is therapy of people with chronic kidney disease ONTARGET?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney Diseases; Ramipril; Telmisartan; Treatment Outcome | 2010 |
ONTARGET should not be over interpreted.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney Diseases; Ramipril; Telmisartan; Treatment Outcome | 2010 |
Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autoimmune Diseases; Benzimidazoles; Benzoates; Cardiomyopathy, Dilated; Chronic Disease; Cytokines; Fibrosis; Heart Failure; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocarditis; Myocardium; Rats; Rats, Inbred Lew; Telmisartan; Ventricular Remodeling | 2010 |
Effect of Telmisartan on local cardiovascular oxidative stress in mouse under chronic intermittent hypoxia condition.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biomarkers; Chronic Disease; Disease Models, Animal; Hypoxia; Male; Mice; Mice, Inbred Strains; Myocardium; NADPH Oxidases; Oxidative Stress; Reference Values; Sleep Apnea, Obstructive; Telmisartan | 2013 |
Effects of telmisartan on the cerebral circulation of hypertensive patients with chronic-stage stroke.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Cerebrovascular Circulation; Chronic Disease; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Stroke; Telmisartan | 2012 |